Publication | Closed Access

Impact of Venetoclax Exposure on Clinical Efficacy and Safety in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia

Hematological MalignancyLymphoid NeoplasiaMedicineHematologyImmunologyAdult T-cell Leukemia-lymphomaOncologyClinical EfficacyVenetoclax ExposureCancer Research